scanx.trade

Sun Pharma Wins US Antitrust Appeal on Generic Lipitor Case

Sun Pharmaceutical logoSun Pharmaceutical
Sig3.59Sen+5.25Env0.00Soc0.00Gov+2.70

Sun Pharmaceutical Industries won a legal appeal in the U.S., as the Third Circuit affirmed summary judgment in its favor in antitrust litigation involving generic Lipitor (atorvastatin). Sun Pharma said it had disclosed the case status in its financial statements throughout the proceedings. Separately, NSE and BSE issued no-objection letters shifting certain shareholders’ classification from promoter group to public under SEBI Regulation 31A, with guidance on future material-event disclosures.

Coverage (4)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro